Evidence map›Paper›PMID 38931410›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Exploring the Potential of Halotolerant Actinomycetes from Rann of Kutch, India: A Study on the Synthesis, Characterization, and Biomedical Applications of Silver Nanoparticles.

Paras Dayma, Nisha Choudhary, Daoud Ali, Saud Alarifi, Pravin Dudhagara, Kuldeep Luhana, Virendra Kumar Yadav, Ashish Patel, Rajesh Patel

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Tackling carbapenem-resistantBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
  6. Green synthesis of silver nanoparticles byFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paras DaymaDepartment of Biosciences, Veer Narmad South Gujarat University, Surat 395007, Gujarat, India.
Nisha ChoudharyDepartment of Life Sciences, Hemchandracharya North Gujarat University, Patan 384265, Gujarat, India.
Daoud AliDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Saud AlarifiDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Pravin DudhagaraDepartment of Biosciences, Veer Narmad South Gujarat University, Surat 395007, Gujarat, India.ORCID 0000-0002-4041-6751
Kuldeep LuhanaDepartment of Biotechnology, Hemchandracharya North Gujarat University, Patan 384265, Gujarat, India.ORCID 0000-0003-3766-4989
Virendra Kumar YadavDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-5448-7676
Ashish PatelDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-4612-1724
Rajesh PatelDepartment of Biosciences, Veer Narmad South Gujarat University, Surat 395007, Gujarat, India.ORCID 0000-0002-4712-1921

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A tremendous increase in the green synthesis of metallic nanoparticles has been noticed in the last decades, which is due to their unique properties at the nano dimension. The present research work deals with synthesis mediated by the actinomycete

Indexed as

actinomycetehalotolerantmultidrug resistanceRann of Kutchsilver nanoparticles

Identifiers

PMID38931410
PMCPMC11206697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.